PortalPublikationenLong-term follow-up after pacemaker implantation in neonates...

Long-term follow-up after pacemaker implantation in neonates and infants

Standard

Long-term follow-up after pacemaker implantation in neonates and infants. / Aellig, Natalie C; Balmer, Christian; Dodge-Khatami, Ali; Rahn, Mariette; Prêtre, René; Bauersfeld, Urs.

in: ANN THORAC SURG, Jahrgang 83, Nr. 4, 04.2007, S. 1420-1423.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Aellig, NC, Balmer, C, Dodge-Khatami, A, Rahn, M, Prêtre, R & Bauersfeld, U 2007, 'Long-term follow-up after pacemaker implantation in neonates and infants', ANN THORAC SURG, Jg. 83, Nr. 4, S. 1420-1423. https://doi.org/10.1016/j.athoracsur.2006.11.042

APA

Aellig, N. C., Balmer, C., Dodge-Khatami, A., Rahn, M., Prêtre, R., & Bauersfeld, U. (2007). Long-term follow-up after pacemaker implantation in neonates and infants. ANN THORAC SURG, 83(4), 1420-1423. https://doi.org/10.1016/j.athoracsur.2006.11.042

Vancouver

Aellig NC, Balmer C, Dodge-Khatami A, Rahn M, Prêtre R, Bauersfeld U. Long-term follow-up after pacemaker implantation in neonates and infants. ANN THORAC SURG. 2007 Apr;83(4):1420-1423. https://doi.org/10.1016/j.athoracsur.2006.11.042

Bibtex

@article{04285758bfd64de4b186c39e3f9e9e4c,
title = "Long-term follow-up after pacemaker implantation in neonates and infants",
abstract = "BACKGROUND: Pacemaker (PM) system implantation in neonates and infants is often complicated by hemodynamic instability, small vessel size, and abnormal cardiovascular anatomy. Thus, an open surgical approach for epicardial lead insertion is often required. We assessed the long-term outcomes after epicardial PM implantation in this age group.METHODS: Between 1992 and 2004, 22 consecutive patients underwent PM implantation within the first year of life. Bipolar steroid-eluting epicardial leads (Medtronic CapSure Epi 10366 and 4968) were inserted through median sternotomy, the sybxyphoid approach, or thoracotomy, and connected to various pulse generators.RESULTS: Pacemakers were implanted at a median age of 35 days (range, 1 to 300). Intracardiac anatomy was abnormal in 17 patients. Indications for PM therapy were heart block in 18 patients and sinus node dysfunction in 4 patients. During a median follow-up of 4.6 years (range, 4 days to 12.8 years), 7 devices were replaced owing to end of battery life (n = 6) or elective device repositioning (n = 1), at a median of 4.1 years (range, 1 to 7.8). One dislodged ventricular lead and 2 atrial lead sensing failures were observed. Sensing, pacing thresholds, and lead impedances showed good implant and stable follow-up values.CONCLUSIONS: Pacemaker-associated morbidity is low. Pacemaker system complications with epicardial leads are rare. Battery life is relatively shorter compared with children and adults because of the fast heart rate and complete PM dependency in most of these children. Even for neonates and infants, modern pacemaker therapy is feasible, safe, and effective.",
keywords = "Age Factors, Bradycardia/congenital, Cardiac Pacing, Artificial/methods, Cohort Studies, Confidence Intervals, Female, Follow-Up Studies, Heart Block/congenital, Humans, Infant, Infant, Newborn, Male, Pacemaker, Artificial, Probability, Prosthesis Implantation, Retrospective Studies, Risk Assessment, Survival Analysis, Time Factors, Treatment Outcome",
author = "Aellig, {Natalie C} and Christian Balmer and Ali Dodge-Khatami and Mariette Rahn and Ren{\'e} Pr{\^e}tre and Urs Bauersfeld",
year = "2007",
month = apr,
doi = "10.1016/j.athoracsur.2006.11.042",
language = "English",
volume = "83",
pages = "1420--1423",
journal = "ANN THORAC SURG",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "4",

}

RIS

TY - JOUR

T1 - Long-term follow-up after pacemaker implantation in neonates and infants

AU - Aellig, Natalie C

AU - Balmer, Christian

AU - Dodge-Khatami, Ali

AU - Rahn, Mariette

AU - Prêtre, René

AU - Bauersfeld, Urs

PY - 2007/4

Y1 - 2007/4

N2 - BACKGROUND: Pacemaker (PM) system implantation in neonates and infants is often complicated by hemodynamic instability, small vessel size, and abnormal cardiovascular anatomy. Thus, an open surgical approach for epicardial lead insertion is often required. We assessed the long-term outcomes after epicardial PM implantation in this age group.METHODS: Between 1992 and 2004, 22 consecutive patients underwent PM implantation within the first year of life. Bipolar steroid-eluting epicardial leads (Medtronic CapSure Epi 10366 and 4968) were inserted through median sternotomy, the sybxyphoid approach, or thoracotomy, and connected to various pulse generators.RESULTS: Pacemakers were implanted at a median age of 35 days (range, 1 to 300). Intracardiac anatomy was abnormal in 17 patients. Indications for PM therapy were heart block in 18 patients and sinus node dysfunction in 4 patients. During a median follow-up of 4.6 years (range, 4 days to 12.8 years), 7 devices were replaced owing to end of battery life (n = 6) or elective device repositioning (n = 1), at a median of 4.1 years (range, 1 to 7.8). One dislodged ventricular lead and 2 atrial lead sensing failures were observed. Sensing, pacing thresholds, and lead impedances showed good implant and stable follow-up values.CONCLUSIONS: Pacemaker-associated morbidity is low. Pacemaker system complications with epicardial leads are rare. Battery life is relatively shorter compared with children and adults because of the fast heart rate and complete PM dependency in most of these children. Even for neonates and infants, modern pacemaker therapy is feasible, safe, and effective.

AB - BACKGROUND: Pacemaker (PM) system implantation in neonates and infants is often complicated by hemodynamic instability, small vessel size, and abnormal cardiovascular anatomy. Thus, an open surgical approach for epicardial lead insertion is often required. We assessed the long-term outcomes after epicardial PM implantation in this age group.METHODS: Between 1992 and 2004, 22 consecutive patients underwent PM implantation within the first year of life. Bipolar steroid-eluting epicardial leads (Medtronic CapSure Epi 10366 and 4968) were inserted through median sternotomy, the sybxyphoid approach, or thoracotomy, and connected to various pulse generators.RESULTS: Pacemakers were implanted at a median age of 35 days (range, 1 to 300). Intracardiac anatomy was abnormal in 17 patients. Indications for PM therapy were heart block in 18 patients and sinus node dysfunction in 4 patients. During a median follow-up of 4.6 years (range, 4 days to 12.8 years), 7 devices were replaced owing to end of battery life (n = 6) or elective device repositioning (n = 1), at a median of 4.1 years (range, 1 to 7.8). One dislodged ventricular lead and 2 atrial lead sensing failures were observed. Sensing, pacing thresholds, and lead impedances showed good implant and stable follow-up values.CONCLUSIONS: Pacemaker-associated morbidity is low. Pacemaker system complications with epicardial leads are rare. Battery life is relatively shorter compared with children and adults because of the fast heart rate and complete PM dependency in most of these children. Even for neonates and infants, modern pacemaker therapy is feasible, safe, and effective.

KW - Age Factors

KW - Bradycardia/congenital

KW - Cardiac Pacing, Artificial/methods

KW - Cohort Studies

KW - Confidence Intervals

KW - Female

KW - Follow-Up Studies

KW - Heart Block/congenital

KW - Humans

KW - Infant

KW - Infant, Newborn

KW - Male

KW - Pacemaker, Artificial

KW - Probability

KW - Prosthesis Implantation

KW - Retrospective Studies

KW - Risk Assessment

KW - Survival Analysis

KW - Time Factors

KW - Treatment Outcome

U2 - 10.1016/j.athoracsur.2006.11.042

DO - 10.1016/j.athoracsur.2006.11.042

M3 - SCORING: Journal article

C2 - 17383349

VL - 83

SP - 1420

EP - 1423

JO - ANN THORAC SURG

JF - ANN THORAC SURG

SN - 0003-4975

IS - 4

ER -